Condition: Covid19 · Neurocognitive Dysfunction · Sponsor: Assaf-Harofeh Medical Center
Post-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for months after recovering from the virus, and no treatment is known to date. The aim of this study is to compare the effect of HBOT vs. Sham on post COVID-19 syndrome
This description comes directly from the study's public registry record.
Shani Zilberman-Itskovich, Dr. · 97289979383 · shani.zilberman@mail.huji.ac.il
Shai Efrati, Prof. · efratishai@outlook.com
Always discuss trial participation with your own doctor first.
| Assaf-Harofeh medical center | Ẕerifin, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04647656